Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Intra-Cellular Therapies, Inc. (ITCI)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Drug Manufacturers—Specialty & Generic
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
27 Feb 2024
VAN NOSTRAND ROBERT L
Director
Intra-Cellular Therapies, Inc.
(ITCI)
19,960
-50%
20,000
$72.93
$1,458,650.00
SELL
26 Feb 2024
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
57,619
-31%
26,328
$68.68
$1,808,253.40
SELL
23 Feb 2024
Durgam Suresh K.
EVP, Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
12,200
-25%
4,112
$70.17
$288,534.25
SELL
23 Feb 2024
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
37,407
-17%
7,907
$70.13
$554,491.00
SELL
23 Feb 2024
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
7,607
-50%
7,907
$69.53
$549,784.06
SELL
23 Feb 2024
Hineline Lawrence J.
SVP of Finance, CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
7,155
-65%
13,337
$69.43
$925,961.10
SELL
23 Feb 2024
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,072,299
-2%
22,590
$69.79
$1,576,464.40
SELL
1 Feb 2024
Durgam Suresh K.
EVP, Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
9,540
-39%
6,167
$67.19
$414,354.80
SELL
1 Feb 2024
Hineline Lawrence J.
SVP of Finance, CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
185
-98%
11,183
$66.62
$745,036.56
SELL
1 Feb 2024
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
36,604
-24%
11,860
$67.15
$796,367.44
SELL
1 Feb 2024
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,067,759
-3%
33,885
$67.07
$2,272,693.50
SELL
1 Feb 2024
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
714
-94%
11,860
$66.42
$787,719.44
SELL
16 Jan 2024
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,050,629
-15%
191,362
$66.27
$12,680,892.00
SELL
11 Jan 2024
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
31,846
-61%
50,000
$66.83
$3,341,698.50
SELL
2 Jan 2024
Durgam Suresh K.
EVP, Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
24,855
-71%
62,282
$70.60
$4,397,113.00
SELL
13 Dec 2023
Durgam Suresh K.
EVP, Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
0
-100%
21,262
$65.00
$1,382,030.00
SELL
6 Nov 2023
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
45,339
-48%
42,393
$55.63
$2,358,151.50
SELL
18 Sep 2023
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,050,309
-8%
100,000
$53.94
$5,394,065.00
SELL
7 Aug 2023
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
45,339
-54%
55,300
$58.79
$3,251,087.00
SELL
14 Jun 2023
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
47,627
-63%
81,854
$63.97
$5,236,329.50
SELL
17 Apr 2023
VAN NOSTRAND ROBERT L
Director
Intra-Cellular Therapies, Inc.
(ITCI)
9,345
-51%
10,000
$63.00
$630,000.00
SELL
28 Mar 2023
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
55,522
-21%
15,604
$54.31
$847,379.90
SELL
1 Mar 2023
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
49,199
-12%
7,241
$50.01
$362,122.40
SELL
23 Feb 2023
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,100,309
-2%
22,590
$47.03
$1,062,407.60
SELL
23 Feb 2023
Durgam Suresh K.
SVP, Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
23,104
-25%
7,906
$47.14
$372,688.84
SELL
23 Feb 2023
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
0
-100%
7,906
$47.03
$371,819.16
SELL
23 Feb 2023
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
0
-100%
7,455
$47.03
$350,608.66
SELL
23 Feb 2023
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
56,440
-6%
4,046
$47.12
$190,647.52
SELL
18 Feb 2023
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,794
-97%
64,411
$49.34
$3,178,354.50
SELL
18 Feb 2023
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,105,262
-2%
27,848
$46.83
$1,304,000.40
SELL
18 Feb 2023
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,843
-85%
11,139
$46.84
$521,698.70
SELL
18 Feb 2023
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
53,338
-6%
3,898
$47.01
$183,246.31
SELL
18 Feb 2023
Durgam Suresh K.
SVP, Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
24,785
-25%
8,354
$46.84
$391,303.94
SELL
19 Dec 2022
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
29,233
-14%
5,000
$50.82
$254,100.00
SELL
13 Dec 2022
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,100,309
-2%
33,083
$55.00
$1,819,565.00
SELL
1 Dec 2022
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
22,796
-68%
50,000
$53.73
$2,686,514.00
SELL
7 Nov 2022
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
39,233
-20%
10,000
$52.30
$523,023.00
SELL
21 Sep 2022
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
33,303
-66%
65,164
$45.63
$2,973,406.00
SELL
11 Aug 2022
VAN NOSTRAND ROBERT L
Director
Intra-Cellular Therapies, Inc.
(ITCI)
10,543
-73%
30,000
$57.13
$1,713,975.00
SELL
11 Aug 2022
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
44,233
-18%
10,000
$59.22
$592,200.00
SELL
8 Apr 2022
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
114,211
-43%
86,348
$64.37
$5,558,051.00
SELL
16 Mar 2022
RIGGS RORY B
Director
Intra-Cellular Therapies, Inc.
(ITCI)
15,736
-93%
226,670
$60.10
$13,623,980.00
SELL
7 Mar 2022
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
38,980
-33%
20,000
$53.14
$1,062,750.00
SELL
2 Mar 2022
Durgam Suresh K.
Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
23,104
-25%
8,037
$56.28
$452,312.66
SELL
23 Feb 2022
Durgam Suresh K.
Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
33,984
-10%
4,046
$52.27
$211,467.92
SELL
23 Feb 2022
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
4,188
-65%
7,906
$51.98
$410,933.40
SELL
23 Feb 2022
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
4,083
-64%
7,454
$51.97
$387,349.12
SELL
23 Feb 2022
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
50,585
-13%
7,906
$52.21
$412,810.06
SELL
23 Feb 2022
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,105,807
-2%
22,589
$51.98
$1,174,073.50
SELL
18 Feb 2022
Durgam Suresh K.
Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
28,638
-12%
4,177
$55.29
$230,958.19
SELL
18 Feb 2022
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
4,550
-70%
11,139
$55.40
$617,100.40
SELL
18 Feb 2022
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
4,627
-69%
10,443
$55.40
$578,506.25
SELL
18 Feb 2022
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
49,946
-18%
11,139
$55.29
$615,827.06
SELL
18 Feb 2022
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,107,134
-2%
27,847
$55.39
$1,542,413.00
SELL
18 Jan 2022
Durgam Suresh K.
Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
23,104
-21%
6,223
$42.03
$261,552.69
SELL
8 Jan 2022
Durgam Suresh K.
Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
34,677
-16%
6,870
$40.76
$280,020.10
SELL
8 Jan 2022
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
17,135
-53%
19,639
$40.77
$800,774.10
SELL
8 Jan 2022
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
16,534
-54%
19,639
$40.76
$800,420.25
SELL
8 Jan 2022
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
63,526
-24%
20,948
$40.78
$854,254.80
SELL
8 Jan 2022
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,130,559
-3%
41,896
$40.78
$1,708,428.60
SELL
21 Dec 2021
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
154,243
-53%
176,863
$47.56
$8,412,278.00
SELL
21 Dec 2021
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
149,538
-53%
175,000
$47.59
$8,328,664.00
BUY
21 Dec 2021
Josh Gottheimer
Congressman (House)
Intra-Cellular Therapies, Inc.
(ITCI)
N/A
N/A
N/A
$1,001 - $15,000
SELL
15 Oct 2021
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
52,085
-20%
13,448
$40.86
$549,551.25
SELL
14 Oct 2021
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,094,467
-4%
50,000
$40.00
$2,000,000.00
SELL
14 Jun 2021
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
48,980
-27%
18,289
$42.27
$773,076.06
SELL
27 May 2021
Alafi Christopher D
Director
Intra-Cellular Therapies, Inc.
(ITCI)
95,000
-33%
47,325
$40.10
$1,897,746.00
SELL
21 May 2021
Alafi Christopher D
Director
Intra-Cellular Therapies, Inc.
(ITCI)
142,325
-16%
27,675
$40.45
$1,119,490.20
SELL
2 Mar 2021
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
72,269
-17%
15,250
$34.93
$532,682.50
SELL
18 Feb 2021
Durgam Suresh K.
Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
23,304
-10%
2,734
$39.25
$107,309.52
SELL
18 Feb 2021
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,100
-91%
11,139
$39.24
$437,132.90
SELL
18 Feb 2021
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,200
-89%
10,442
$39.23
$409,625.34
SELL
18 Feb 2021
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
45,939
-10%
5,184
$39.22
$203,307.83
SELL
18 Feb 2021
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,136,492
-2%
27,847
$39.23
$1,092,435.80
SELL
8 Jan 2021
Durgam Suresh K.
Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
17,584
-19%
4,367
$32.12
$140,258.72
SELL
8 Jan 2021
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,936
-91%
19,638
$32.03
$628,977.50
SELL
8 Jan 2021
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
2,376
-89%
19,638
$32.02
$628,768.94
SELL
8 Jan 2021
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
39,384
-19%
9,684
$32.02
$310,081.70
SELL
8 Jan 2021
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,137,977
-3%
41,896
$32.01
$1,341,260.10
SELL
3 Jan 2021
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
3,174
-83%
16,160
$31.30
$505,834.10
SELL
3 Jan 2021
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
3,450
-82%
15,810
$31.31
$495,008.00
SELL
3 Jan 2021
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,153,820
-4%
48,341
$31.30
$1,513,271.40
SELL
17 Nov 2020
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
3,761
-95%
79,425
$27.62
$2,193,446.20
SELL
11 Nov 2020
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
0
-100%
28,034
$25.41
$712,343.94
SELL
10 Nov 2020
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,132,523
-4%
50,000
$26.34
$1,317,100.50
SELL
4 Nov 2020
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,163,392
-4%
50,000
$25.00
$1,250,000.00
SELL
15 Oct 2020
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
28,120
-19%
6,792
$26.80
$182,025.60
BUY
14 Sep 2020
Alafi Christopher D
Director
Intra-Cellular Therapies, Inc.
(ITCI)
4,743,770
+1%
49,500
$29.60
$1,465,200.00
BUY
11 Sep 2020
Alafi Christopher D
Director
Intra-Cellular Therapies, Inc.
(ITCI)
4,694,270
+0%
21,000
$28.08
$589,680.00
SELL
9 Sep 2020
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
8,034
-83%
41,983
$31.14
$1,307,350.60
SELL
14 May 2020
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
39,140
-19%
9,602
$20.04
$192,424.10
SELL
11 May 2020
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
14,374
-79%
57,297
$20.04
$1,148,037.10
SELL
11 May 2020
LERNER RICHARD A
Director
Intra-Cellular Therapies, Inc.
(ITCI)
93,813
-3%
3,500
$20.50
$71,750.00
SELL
9 Jan 2020
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
191
-99%
19,638
$26.16
$513,730.06
SELL
9 Jan 2020
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
18,800
-51%
19,638
$26.16
$513,730.06
SELL
9 Jan 2020
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,204,707
-3%
41,895
$26.16
$1,095,973.20
SELL
8 Jan 2020
Satlin Andrew
EVP and Chief Medical Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
11,338
-50%
11,573
$26.16
$302,749.70
SELL
6 Jan 2020
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
17,704
-54%
21,458
$30.34
$651,006.94
SELL
6 Jan 2020
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
36,391
-37%
21,458
$30.29
$650,003.00
SELL
6 Jan 2020
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,182,366
-3%
45,598
$30.28
$1,380,880.40
SELL
31 Dec 2019
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
6,375
-55%
7,807
$32.43
$253,213.97
SELL
31 Dec 2019
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
25,807
-23%
7,807
$32.43
$253,165.22
SELL
31 Dec 2019
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,158,485
-1%
17,478
$32.45
$567,230.30
SELL
23 Dec 2019
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
25,232
-37%
15,032
$25.50
$383,316.00
SELL
15 Oct 2019
Neumann Mark
EVP, Chief Commercial Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
6,674
-50%
6,774
$8.25
$55,885.50
BUY
10 Sep 2019
Alafi Christopher D
Director, 10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
4,191,819
+13%
485,000
$10.26
$4,974,677.50
BUY
30 Aug 2019
Alafi Christopher D
Director
Intra-Cellular Therapies, Inc.
(ITCI)
4,188,270
+3%
125,000
$8.52
$1,065,212.50
SELL
18 Jun 2019
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
54,233
-15%
10,000
$55.00
$550,000.00
BUY
12 Jun 2019
Alafi Christopher D
Director
Intra-Cellular Therapies, Inc.
(ITCI)
16,226
+110%
170,000
$11.73
$1,993,792.90
BUY
14 May 2019
Alafi Christopher D
Director
Intra-Cellular Therapies, Inc.
(ITCI)
4,053,270
+2%
100,000
$12.56
$1,256,350.00
SELL
27 Feb 2019
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
25,232
-3%
1,000
$15.00
$15,000.00
SELL
4 Jan 2019
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
191
-99%
24,566
$11.58
$284,418.20
SELL
4 Jan 2019
Davis Robert E
SVP, Chief Scientific Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
46,691
-17%
9,564
$11.46
$109,630.06
SELL
4 Jan 2019
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
17,032
-59%
24,566
$11.58
$284,383.38
SELL
4 Jan 2019
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,138,707
-4%
52,202
$11.58
$604,310.10
SELL
4 Jan 2019
Vanover Kimberly E.
SVP, Early Stage Clinical Dev., Officer
Intra-Cellular Therapies, Inc.
(ITCI)
27,068
-27%
10,156
$11.52
$116,979.32
SELL
31 Dec 2018
Halstead Michael
EVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
191
-97%
7,807
$11.09
$86,579.63
SELL
31 Dec 2018
Davis Robert E
SVP, Chief Scientific Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
34,744
-12%
4,834
$11.11
$53,705.74
SELL
31 Dec 2018
Hineline Lawrence J.
SVP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
17,032
-31%
7,807
$11.09
$86,579.63
SELL
31 Dec 2018
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,138,707
-1%
17,478
$11.09
$193,831.02
SELL
31 Dec 2018
Vanover Kimberly E.
SVP, Early Stage Clinical Dev., Officer
Intra-Cellular Therapies, Inc.
(ITCI)
16,861
-22%
4,834
$11.10
$53,657.40
SELL
4 Dec 2018
Davis Robert E
SVP, Chief Scientific Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
30,256
-2%
899
$13.53
$12,163.47
SELL
9 Nov 2018
MARCUS JOEL S
Director
Intra-Cellular Therapies, Inc.
(ITCI)
78,742
-28%
32,000
$18.17
$581,580.00
SELL
15 Feb 2018
Hineline Lawrence J.
VP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
17,032
-74%
49,700
$20.02
$995,164.60
SELL
22 Jan 2018
Halstead Michael
SVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
191
-99%
25,500
$18.03
$459,765.03
SELL
8 Jan 2018
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,088,707
-0%
6,604
$17.48
$115,437.91
SELL
8 Jan 2018
Vanover Kimberly E.
SVP, Clinical Development, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
12,373
-5%
772
$17.46
$13,479.12
SELL
3 Jan 2018
Halstead Michael
SVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
25,691
-14%
4,220
$16.39
$69,179.40
SELL
3 Jan 2018
Davis Robert E
SVP, Chief Scientific Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
29,397
-3%
1,115
$15.60
$17,394.00
SELL
3 Jan 2018
Hineline Lawrence J.
VP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
66,732
-7%
5,062
$16.34
$82,724.94
SELL
3 Jan 2018
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,095,311
-1%
11,257
$17.08
$192,269.56
SELL
3 Jan 2018
Vanover Kimberly E.
SVP, Clinical Development, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
13,145
-8%
1,185
$17.37
$20,583.45
BUY
29 Dec 2017
VAN NOSTRAND ROBERT L
Director
Intra-Cellular Therapies, Inc.
(ITCI)
3,656
+10%
345
$14.48
$4,995.60
BUY
29 Dec 2017
LERNER RICHARD A
Director
Intra-Cellular Therapies, Inc.
(ITCI)
9,570
+11%
949
$14.48
$13,741.52
BUY
29 Dec 2017
RIGGS RORY B
Director
Intra-Cellular Therapies, Inc.
(ITCI)
36,608
+2%
1,001
$14.48
$14,494.48
BUY
29 Dec 2017
Alafi Christopher D
Director, 10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
745,467
+0%
1,001
$14.48
$14,494.48
SELL
11 Dec 2017
LERNER RICHARD A
Director
Intra-Cellular Therapies, Inc.
(ITCI)
53,000
-11%
7,000
$15.09
$105,630.00
SELL
4 Dec 2017
Davis Robert E
SVP, Chief Scientific Officer, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
27,864
-2%
650
$15.00
$9,750.00
BUY
22 Nov 2017
Alafi Christopher D
Director, 10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
744,466
+1%
10,000
$15.55
$155,500.00
SELL
30 Oct 2017
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,088,707
-1%
18,750
$15.75
$295,312.50
BUY
2 Oct 2017
ALAFI CAPITAL CO LLC
10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,953,270
+6%
258,065
$15.50
$4,000,007.50
BUY
2 Oct 2017
ALAFI MOSHE
10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,953,270
+6%
258,065
$15.50
$4,000,007.50
BUY
29 Sep 2017
Alafi Christopher D
Director, 10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,953,270
+6%
258,065
$15.50
$4,000,007.50
BUY
1 May 2017
Roger W. Marshall
Congressman (House)
Intra-Cellular Therapies, Inc.
(ITCI)
N/A
N/A
N/A
$1,001 - $15,000
SELL
5 Jan 2017
Halstead Michael
SVP and General Counsel, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
21,506
-6%
1,601
$16.55
$26,496.55
SELL
5 Jan 2017
Hineline Lawrence J.
VP of Finance CFO, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
63,389
-2%
1,918
$16.58
$31,800.44
SELL
5 Jan 2017
Mates Sharon
Chairman, President & CEO, Director, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
1,088,707
-0%
4,081
$16.55
$67,540.55
SELL
5 Jan 2017
Vanover Kimberly E.
SVP, Clinical Development, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
10,128
-7%
800
$16.59
$13,272.00
SELL
15 Dec 2016
Vanover Kimberly E.
SVP, Clinical Development, Officer
Intra-Cellular Therapies, Inc.
(ITCI)
2,500
-78%
9,375
$15.23
$142,772.88
BUY
6 Dec 2016
ALAFI CAPITAL CO LLC
10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,695,205
+1%
65,000
$16.27
$1,057,483.20
BUY
6 Dec 2016
ALAFI MOSHE
10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,695,205
+1%
65,000
$16.27
$1,057,483.20
BUY
6 Dec 2016
Alafi Christopher D
Director, 10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,695,205
+1%
65,000
$16.27
$1,057,483.20
BUY
14 Nov 2016
ALAFI CAPITAL CO LLC
10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,630,205
+0%
34,000
$14.50
$492,969.40
BUY
14 Nov 2016
ALAFI MOSHE
10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,630,205
+0%
34,000
$14.50
$492,969.40
BUY
14 Nov 2016
Alafi Christopher D
Director, 10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
3,630,205
+0%
34,000
$14.50
$492,969.40
BUY
29 Feb 2016
Alafi Christopher D
Director, 10% Owner
Intra-Cellular Therapies, Inc.
(ITCI)
728,828
+15%
100,000
$29.70
$2,970,300.00
Home